Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-m8qmq Total loading time: 0 Render date: 2024-04-25T06:24:11.429Z Has data issue: false hasContentIssue false

Chapter 26 - Rubella, Measles, Mumps, Varicella, and Parvovirus in Pregnancy (Content last reviewed: 11th November 2020)

Published online by Cambridge University Press:  15 November 2017

By
Laura E. Riley
Edited by
David James ,
Philip Steer ,
Carl Weiner ,
Bernard Gonik  and
Stephen Robson
David James
Affiliation:
University of Nottingham
Philip Steer
Affiliation:
Imperial College London
Carl Weiner
Affiliation:
University of Kansas
Bernard Gonik
Affiliation:
Wayne State University, Detroit
Stephen Robson
Affiliation:
University of Newcastle
Get access

Summary

Rubella (German measles or “third disease”) is an exanthematous disease caused by a single-stranded RNA virus of the togavirus family.

Type
Chapter
Information
High-Risk Pregnancy
Management Options
 , pp. 644 - 658
Publisher: Cambridge University Press
First published in: 2017

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Further Reading

Davidkin, I. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20 year follow-up. J Infect Dis 2008; 197: 950–6.Google Scholar
Enders, G, Miller, E, Cradock-Watson, J, et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994; 343: 1547–50.Google Scholar
Enders, M, Weidner, A, Rosenthal, T, et al. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops. J Infect Dis 2008; 197: 58–62.Google Scholar
Enders, M, Weidner, A, Zoellner, I, Searle, K, Enders, G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004; 24: 513–18.Google Scholar
McQuillan, GM, Kruszon-Moran, D, Hyde, TB, et al. Seroprevalence of measles antibody in the US population, 1999–2004. J Infect Dis 2007; 196: 1459–64.Google Scholar
Siegel, M. Congenital malformations following chickenpox, measles, mumps, and hepatitis: results of a cohort study. JAMA 1993; 226: 1521–4.Google Scholar
Wilson, E, Goss, MA, Marin, M, et al. Varicella vaccine exposure during pregnancy: data from 10 years of the Pregnancy Registry. J Infect Dis 2008; 197 (Suppl 2): S178–84.Google Scholar

References

Gershon, AA. Rubella virus (German measles). In Mandell, GL, Douglas, RG, Bennett, JE (eds), Principles and Practice of Infectious Diseases, 3rd edn. New York, NY: Churchill Livingstone, 1990, pp. 1242–7.Google Scholar
Cochi, SL, Edmonds, LE, Dyer, K, et al. Congenital rubella syndrome in the United States, 1970–1985. Am J Epidemiol 1989; 129: 349–61.Google Scholar
Grossman, JH. Why congenital rubella continues to occur. Contemp Obstet Gynecol 1990; 36: 50–4.Google Scholar
Freij, BJ, South, MA, Sever, JL, et al. Maternal rubella and the congenital rubella syndrome. Clin Perinatol 1988; 15: 247–57.Google Scholar
McIntosh, EDG, Menser, MA. A fifty-year follow-up of congenital rubella. Lancet 1992; 340: 414–15.Google Scholar
Miller, E, Cradock-Watson, JE, Pollock, TM. Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 1982; 2: 781–4.Google Scholar
Centers for Disease Control and Prevention (CDC). Rubella and congenital rubella syndrome: United States, 1994–1997. MMWR Morb Mortal Wkly Rep 1997; 46: 350–3.Google Scholar
Centers for Disease Control and Prevention (CDC). Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013. MMWR Morb Mortal Wkly Rep 2013; 62 (RR-4): 1–34.Google Scholar
Bukasa, A, Campbell, H, Brown, K, et al. Rubella infection in pregnancy and congenital rubella in United Kingdom, 2003 to 2016. Euro Surveill 2018; 23(19): 17–00381. https://doi.org/10.2807/1560-7917.ES.2018.23.19.17-00381.Google Scholar
Cordier, AG, Vauloup-Fellous, C, Grangeot-Keros, L, et al. Pitfalls in the diagnosis of congenital rubella syndrome in the first trimester of pregnancy. Prenat Diagn 2012; 32: 496–7Google Scholar
Centers for Disease Control and Prevention (CDC). Notice to readers. Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Morb Mortal Wkly Rep 2001; 50: 1117.Google Scholar
Davidkin, I. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20 year follow-up. J Infect Dis 2008; 197: 950–6.Google Scholar
O’Shea, S, Best, JM, Banatvala, JE. Viremia, virus excretion, and antibody responses after challenge in volunteers with low levels of antibody to rubella virus. J Infect Dis 1983; 148: 639–47.Google ScholarPubMed
Enders, G, Calm, A, Shaub, J. Rubella embryopathy after previous maternal rubella vaccination. Infection 1984; 12: 96–8.Google Scholar
Bart, SW, Stetler, HC, Preblud, SR, et al. Fetal risk associated with rubella vaccine: An update. Rev Infect Dis 1985; 7 (Suppl 1): S95–102.Google Scholar
American College of Obstetricians and Gynecologists. Immunization during pregnancy (ACOG Committee Opinion No. 282). Obstet Gynecol 2003; 101: 207–12.Google Scholar
Badilla, X, Morice, A, Avila-Aguero, ML, et al. Fetal risk associated with rubella vaccination during pregnancy. Pediatr Infect Dis J 2007; 26: 830–5.Google Scholar
Daffos, F, Forestier, F, Grangeot-Keros, L, et al. Prenatal diagnosis of congenital rubella. Lancet 1984; 2: 1–3.Google Scholar
Bosma, TJ, Corbett, KM, O’Shea, S, et al. PCR for detection of rubella virus RNA in clinical samples. J Clin Microbiol 1995; 33: 1075–9.Google Scholar
Ho-Terry, L, Terry, GM, Londesborough, P. Diagnosis of foetal rubella virus infection by polymerase chain reaction. J Gen Virol 1990; 71: 1607–11.Google Scholar
Tanemura, M, Suzumori, K, Yagami, Y, Katow, S. Diagnosis of fetal rubella infection with reverse transcription and nested polymerase chain reaction: a study of 34 cases diagnosed in fetuses. Am J Obstet Gynecol 1996; 174: 578–82.Google Scholar
Modlin, JF. Measles virus. In Belshe, RB (ed.), Human Virology. Littleton, MA: PSG Publishing, 1984, pp. 333–60.Google Scholar
Gavish, D, Kleinman, Y, Morag, A, Chajek-Shaul, T. Hepatitis and jaundice associated with measles in young adults. An analysis of 65 cases. Arch Intern Med 1983; 143: 674–7.Google Scholar
Gershon, AA. Chickenpox, measles and mumps. In Remington, JS, Klein, JO, Wilson, CB, et al. (eds), Infectious Diseases of the Fetus and Newborn Infant, 7th edn. Philadelphia, PA: Elsevier Saunders, 2011, pp. 661–705.Google Scholar
Phadke, VK, Bednarczyk, RA, Salmon, DA, Omer, SB. Association between vaccine refusal and vaccine-preventable diseases in the United States: a review of measles and pertussis. JAMA 2016; 315: 1149–58. https://doi.org/10.1001/jama.2016.1353.Google Scholar
Parker Fiebelkorn, A, Redd, SB, Gallagher, K, et al. Measles in the United States during the postelimination era. J Infect Dis 2010; 202: 1520–8.Google Scholar
Eberhart-Phillips, JE, Frederick, PD, Baron, RC, Mascola, L. Measles in pregnancy: a descriptive study of 58 cases. Obstet Gynecol 1993; 82: 797–801.Google Scholar
Atmar, RL, Englund, JA, Hammill, H. Complications of measles during pregnancy. Clin Infect Dis 1992; 14: 217–26.Google Scholar
Ogbuanu, IU, Zeko, S, Chu, SY, et al. Maternal, fetal, and neonatal outcomes associated with measles during pregnancy: Namibia, 2009–2010. Clin Infect Dis 2014; 58: 1086–92.Google Scholar
Moroi, K, Saito, S, Durata, T, et al. Fetal death associated with measles virus infection of the placenta. Am J Obstet Gynecol 1991; 164: 107–8.Google Scholar
Stein, SJ, Greenspoon, JS. Rubeola during pregnancy. Obstet Gynecol 1991; 78: 925–9.Google Scholar
de Swart, RL. The pathogenesis of measles revisited. Pediatr Infect Dis J 2008; 27: S84–8.Google Scholar
Korones, SB. Uncommon virus infections of the mother, fetus, and newborn: influenza, mumps, and measles. Clin Perinatal 1988; 15: 259–72.Google Scholar
Siegel, M. Congenital malformations following chickenpox, measles, mumps, and hepatitis: results of a cohort study. JAMA 1993; 226: 1521–4.Google Scholar
Nahmias, AJ, Armstrong, G. Mumps virus and endocardial fibroelastosis. N Engl J Med 1966; 275: 1448–50.Google Scholar
Hersh, BS, Fine, PE, Kent, WK. Mumps outbreak in a highly vaccinated population. J Pediatr 1991; 119: 187–93.Google Scholar
Centers for Disease Control and Prevention (CDC). Updated recommendations for isolation of persons with mumps. MMWR Morb Mortal Wkly Rep 2008; 57: 1103–5.Google Scholar
Whitley, RJ. Varicella-zoster virus. In Mandell, GL, Douglas, RG, Bennett, JE (eds), Principles and Practice of Infectious Diseases, 3rd edn. New York, NY: Churchill Livingstone, 1990, pp. 1153–9.Google Scholar
Pahud, BA, Glaser, CA, Dekker, CL, et al. Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis 2011; 203: 316–23.Google Scholar
Harris, RE, Rhoades, ER. Varicella pneumonia complicating pregnancy: report of a case and review of literature. Obstet Gynecol 1965; 25: 734–6.Google Scholar
Harger, JH, Ernest, JM, Thurnau, GR, et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis 2002; 185: 422–7.Google Scholar
Haake, DA, Zakowski, PC, Haake, DL, et al. Early treatment for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review. Rev Infect Dis 1990; 12: 788–98.Google Scholar
Smego, RA, Asperilla, MO. Use of acyclovir for varicella pneumonia during pregnancy. Obstet Gynecol 1991; 78: 1112–16.Google Scholar
Balducci, J, Rodis, JR, Rosengren, S, et al. Pregnancy outcome following first-trimester varicella infection. Obstet Gynecol 1992; 79: 5–6.Google Scholar
Pastuszak, AL, Levy, M, Schick, B, et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994; 330: 901–5.Google Scholar
Paryani, SG, Arvin, AM. Intrauterine infection with varicella-zoster virus after maternal varicella. N Engl J Med 1986; 314: 1542–6.Google Scholar
Enders, G, Miller, E, Cradock-Watson, J, et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994; 343: 1547–50.Google Scholar
Harger, JH, Ernest, JM, Thurnau, GR, et al. Frequency of congenital varicella syndrome in prospective cohort of 347 pregnant women. Obstet Gynecol 2002; 100: 260–5.Google Scholar
Mattson, SN, Jones, KL, Gramling, LJ, et al. Neurodevelopmental follow-up of children of women infected with varicella during pregnancy: a prospective study. Pediatr Infect Dis J 2003; 22: 809–23.Google Scholar
Meyers, JD. Congenital varicella in term infants: risk reconsidered. J Infect Dis 1974; 129: 215–17.Google Scholar
Cuthbertson, G, Weiner, CP, Giller, RH, et al. Prenatal diagnosis of second trimester congenital varicella syndrome by virus-specific immunoglobulin. J Pediatr 1987; 111: 592–5.Google Scholar
Isada, NB, Paar, DP, Johnson, MP, et al. In utero diagnosis of congenital varicella-zoster virus infection by chorionic villous sampling using polymerase chain reaction. Am J Obstet Gynecol 1991; 165: 1727–30.Google Scholar
Center for Disease Control and Prevention (CDC). Prevention of varicella updated recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2007; 56 (RR-4): 1–40.Google Scholar
Wilson, E, Goss, MA, Marin, M, et al. Varicella vaccine exposure during pregnancy: data from 10 years of the Pregnancy Registry. J Infect Dis 2008; 197 (Suppl 2): S178–84.Google Scholar
Khandaker, G, Marshall, H, Peadon, E, et al. Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Arch Dis Child 2011; 96: 453–6.Google Scholar
Centers for Disease Control and Prevention (CDC). Updated Recommendations for Use of VariZIG: United States, 2013. MMWR Morb Mortal Wkly Rep 2013; 62: 574–6.Google Scholar
Levin, MJ, Duchon, JM, Swamy, GK, Gershon, AA. Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: varicella outcomes and safety results from a large, open-label, expanded-access program. PLoS One 2019; 14(7): e0217749. https://doi.org/10.1371/journal.pone.0217749.Google Scholar
Balfour, HH, Kelly, JM, Suarez, CS, et al. Acyclovir treatment of varicella in otherwise healthy children. J Pediatr 1990; 116: 633–9.Google Scholar
Huang, YC, Lin, TY, Lin, YJ, et al. Prophylaxis of intravenous immunoglobulin and acyclovir in perinatal varicella. Eur J Pediatr 2001; 160: 91–4.Google Scholar
Serjeant, GR, Topley, JM, Mason, K, et al. Outbreak of aplastic crises in sickle cell anemia associated with parvovirus-like agent. Lancet 1981; 2: 595–7.Google Scholar
Thurn, J. Human parvovirus B19: historical and clinical review. Rev Infect Dis 1988; 10: 1005–11.Google Scholar
Kurtzman, GJ, Ozawa, K, Cohen, B, et al. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987; 317: 287–94.Google Scholar
White, DG, Woolf, AD, Mortimer, PP, et al. Human parvovirus arthropathy. Lancet 1985; 1: 419–21.Google Scholar
Anderson, MJ, Lewis, E, Kidd, IM, et al. An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg 1984; 93: 85–93.Google Scholar
Brown, KE, Anderson, SM, Young, NS. Erythrocyte P antigen: cellular receptor for B19. Science 1993; 262: 114–17.Google Scholar
Young, N, Mortimer, P. Viruses and bone marrow failure. Blood 1984; 63: 729–37.Google Scholar
Morey, AL, Ferguson, DJ, Fleming, KA. Ultrastructural features of fetal erythroid precursors infected with parvovirus B19 in-vitro: evidence of cell death by apoptosis. J Pathol 1993; 169: 213–20.Google Scholar
Puccetti, C, Contoli, M, Bonvicini, F, et al. Parvovirus B19 in pregnancy: possible consequences of vertical transmission. Prenat Diagn 2012; 32: 897–902.Google Scholar
Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990; 300: 1166–70.Google Scholar
Gratacos, E, Torres, PJ, Vdal, J, et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infect Dis 1995; 171: 1360–3.Google Scholar
Rodis, JF, Quinn, DL, Gary, W, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol 1990; 163: 1168–71.Google Scholar
Guidozzi, F, Ballot, D, Rothberg, A. Human B19 parvovirus infection in an obstetric population: a prospective study determining fetal outcome. J Reprod Med 1994; 39: 36–8.Google Scholar
Markenson, GR, Yancey, ML. Parvovirus B19 infections in pregnancy. Semin Perinatol 1998; 22: 309–17.Google Scholar
Harger, JH, Adler, SP, Koch, WC, Harger, GF. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 1998; 91: 413–20.Google Scholar
Miller, E, Fairley, CK, Cohen, BJ, Seng, C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998; 105: 174–8.Google Scholar
Enders, M, Weidner, A, Zoellner, I, Searle, K, Enders, G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004; 24: 513–18.Google Scholar
Kinney, J, Anderson, L, Farrar, J, et al. Risk of adverse outcomes of pregnancy after human parvovirus B19 infection. J Infect Dis 1988; 157: 663–7.Google Scholar
Rodis, JF, Rodner, C, Hansen, AA, et al. Long-term outcome of children following maternal human parvovirus B19 infection. Obstet Gynecol 1998; 91: 125–8.Google Scholar
Dembinsk, J, Haverkamp, F, Maara, H, et al. Neurodevelopmental outcome after intrauterine red cell transfusion for parvovirus B19–induced fetal hydrops. BJOG 2002; 109: 1232–4.Google Scholar
De Jong, EP, Lindenburg, IT, van Klink, JM, et al. Intrauterine transfusion for parvovirus B19 infection: long-term neurodevelopmental outcome. Am J Obstet Gynecol 2012; 206: 204.e1–5.Google Scholar
Koch, WC, Adler, SP. Human parvovirus B19 infections in women of childbearing age and within families. Pediatr Infect Dis J 1989; 8: 83–7.Google Scholar
Woolf, AD, Campion, GV, Chishick, A, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 1989; 149: 1153–6.Google Scholar
Gillespie, SM, Cartter, ML, Asch, S, et al. Occupational risk of human parvovirus B19 infection for school and daycare personnel during an outbreak of erythema infectiosum. JAMA 1990; 263: 2061–5.Google Scholar
Valeur-Jensen, AK, Pedersen, CB, Westergaard, T, et al. Risk factors for parvovirus B19 in pregnancy. JAMA 1999; 281: 1099–105.Google Scholar
Schwarz, TF, Jager, G, Gilch, S. Comparison of seven commercial tests for the detection of parvovirus B19–specific IgM. Zentralbl Bakteriol 1997; 285: 525–30.Google Scholar
Torok, T. Human parvovirus B19. In Remington, J, Klein, J (eds), Infectious Diseases of the Fetus and Newborn Infant. Philadelphia, PA: Saunders, 1995, pp. 668–702.Google Scholar
Rotbart, HA. Human parvovirus infections. Annu Rev Med 1990; 41: 25–34.Google Scholar
Torok, TS, Wang, QY, Gary, GW, et al. Prenatal diagnosis on intrauterine infection with parvovirus B19 by the polymerase chain reaction technique. Clin Infect Dis 1992; 14: 149–55.Google Scholar
Clewley, JP. Polymerase chain reaction assay of parvovirus B19 DNA in clinical specimens. J Clin Microbiol 1989; 27: 2647–51.Google Scholar
Yamakawa, Y, Oka, H, Hori, S, et al. Detection of human parvovirus B19 DNA by nest polymerase chain reaction. Obstet Gynecol 1995; 86: 126–9.Google Scholar
Enders, M, Weidner, A, Rosenthal, T, et al. Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops. J Infect Dis 2008; 197: 58–62.Google Scholar
Cosmi, E, Mari, G, Delle-Chiaie, L, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 2002; 187: 1290–93.Google Scholar
Mielke, G, Enders, G. Late onset of hydrops fetalis following intrauterine parvovirus B19 infection. Fetal Diagn Ther 1997; 12: 40–2.Google Scholar
Fairley, C, Smoleniec, J, Caul, O, Miller, E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995; 346: 1335–7.Google Scholar
Schild, RL, Bald, R, Plath, H, et al. Intrauterine management of fetal parvovirus B19 infection. Ultrasound Obstet Gynecol 1999; 13: 161–6.Google Scholar
Sheikh, AU, Ernest, JM, O’Shea, M. Long-term outcome in fetal hydrops from parvovirus B19 infection. Am J Obstet Gynecol 1992; 167: 337–41.Google Scholar
Humphrey, W, Magoon, M, O’Shaughnessy, R. Severe nonimmune hydrops secondary to parvovirus B19 infection: spontaneous reversal in-utero and survival of a term infant. Obstet Gynecol 1991; 78: 900–2.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×